Case study · Pharma launch
How a global pharma company brought to the country the launch of a molecule approved by COFEPRIS and delivered sales kits, KOL gifts and field-team pieces across five sites —Mexico City, Monterrey, Guadalajara, Puebla and Mérida— respecting the parent company's approval matrix, the local language of the packaging and the schedule of an international programme. Figures are anonymised but representative of a real launch coordinated from the Mexico City hub.
The launch was designed at the European parent company with a global brand brief: palette, typography, isotype, allowed and prohibited therapeutic claims. The Mexican affiliate had to land the brief in five sites within 21 days, without drifting from the manual, without changing claims per country and with the auditable documentation the parent requires from every affiliate.
The first problem was time. The activation window — the day each site had to have material in the hands of the sales force and KOLs already briefed — was set by the parent in coordination with FDA and EMA regulatory milestones. Moving that window meant renegotiating with the parent and delaying Asia-Pacific markets. The Mexican affiliate had 21 calendar days to produce, receive, assemble and deliver across five sites.
The second problem was claims. Field and KOL material could carry therapeutic claims in markets where the local registration allowed them, but not in all. The Mexican affiliate had to produce two versions of each piece — one with claims for internal sales-force use, one without claims for HCP deliverables — and keep them physically separated from workshop to delivery point.
The third was coordination. Five sites, five identical dates, one single supplier for all material. Each site had a local commercial lead with decision power over the final KOL, but brand and quality had to be identical across all five. The affiliate's procurement team had to approve a single supplier able to respond in under 21 days, without sacrificing the global approval matrix.
The programme was built as three piece lines with physical separation from the workshop. Line A was the sales-force kit: a technical backpack with compartments, an A5 hard-cover notebook, a roller pen, a card with the per-market claims matrix and an encrypted USB carrying the product scientific dossier. Every piece carried therapeutic claims because the kit was for internal use and was not handed to HCPs.
Line B was the KOL gift: a rigid box with a magnetic closure, a premium apparel piece — a pique tee in the brand colour — a hand-stitched notebook with a fabric-wrapped cover and a two-panel leaflet with the essential scientific information without therapeutic claims not approved in Mexico. The box was handed to the KOL in a face-to-face meeting with the affiliate's medical lead, never by courier.
Line C was the field and internal-recognition piece: a stainless thermal bottle with a laser engraving of the programme name, a cotton tee with the global brand and a metallic pin with the product's isotype. This line was handed to the sales force across the five sites as recognition for completing pre-launch training, and was also distributed within the affiliate as internal gift.
Each site received its material in a single wave, but with differentiated arrival by piece type. Sales-force kits landed at the regional distribution centre 7 days before activation, to give time for internal verification and assembly of individual kits per representative. KOL gifts reached the local medical lead 5 days before, with enough margin to schedule the face-to-face meetings. Internal-recognition pieces were handed out on activation day, during the local launch event.
Each shipment left with a CFDI 4.0 stamped by Corp-Merch, with the Carta Porte 3.0 complement when the move crossed SAT thresholds, and with a consolidated waybill per site so unit transport cost stayed contained. The per-site auditable documentation — technical file for every SKU, approved claims, recipient template — was delivered to the affiliate in a shared folder with European parent access.
The 3,240 pieces reached the five sites inside the 21-day window, with a minimum margin of 3 days for final assembly at each site. Activation day was met identically across the five cities, which let the parent keep the global milestone without renegotiating secondary markets.
Local compliance delivered the complete auditable file to the parent within 7 days of activation, with therapeutic claims physically separated at workshop, warehouse and delivery, and with a signed sheet for every KOL gift. The global post-launch audit opened no observations on Mexico, and the launch was reported as a regional success at the next international committee.
The average unit cost of the piece dropped 9% versus the lab's previous launch of another molecule, mostly because the closed 11-SKU catalogue let us consolidate fabric and stainless purchases, and because all five shipments left the same distribution centre on a single price table. Post-activation file assembly time fell from 14 business days to 7.